Tumor necrosis factor-induced hepatic DNA fragmentation as an early marker of T cell-dependent liver injury in mice

Gastroenterology

Volumn 109, Issue 1, 1995, Pages 166-176

  Gantner, Florian ^a   Leist, Marcel ^a   Jilg, Sabine ^a   Germann, Paul G ^b   Freudenberg, Marina A ^c   Tiegs, Gisa ^a  

^a UNIVERSITY OF KONSTANZ   (Germany)

^b ALTANA PHARMA AG   (Germany)

^c MAX PLANCK INSTITUTE OF IMMUNOBIOLOGY AND EPIGENETICS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; DNA FRAGMENT; GALACTOSAMINE; MONOCLONAL ANTIBODY; STAPHYLOCOCCUS ENTEROTOXIN B; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; CELL DEATH; CONTROLLED STUDY; EARLY DIAGNOSIS; ENZYME ACTIVITY; LIVER INJURY; MARKER GENE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SHOCK; T LYMPHOCYTE ACTIVATION; TARGET CELL;

EID: 0029048073     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/0016-5085(95)90282-1     Document Type: Article

References (53)

1. Apoptosis: a different form of cell death
2. Apoptosis: the biochemistry and molecular biology of programmed cell death
3. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation
4. Tumor necrosis factor can induce both apoptotic and necrotic form of cell lysis
5. Three distinct cell phenotypes of tumor necrosis factor-induced cytotoxicity and their relationship to apoptosis
6. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin
7. Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and d-galactosamine-treated mice
8. Tumor necrosis factor is a terminal mediator in galactosamine/endotoxin hepatitis in mice
9. Sensitization and desensitization to lethal effects of TNF and IL-1
10. T cell activation-associated hepatic injury: mediation by tumor necrosis factors and protection by interleukin 6
11. Concanavalin A-induced T-cell-mediated hepatic injury in mice: the role of tumor necrosis factor
12. T cell-mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: critical role of tumor necrosis factor
13. Pathogenesis of the toxic shock syndrome: T cell mediated lethal shock caused by the superantigen TSST-1
14. Identification of a monoclonal antibody specific for a murine T3 polypeptide
15. Human in vivo antigenic modulation induced by the anti-T cell OKT3 monoclonal antibody
16. Restriction of the human in vivo immune response against the mouse monoclonal antibody OKT3
17. Use of monoclonal antibodies in human transplantation
18. Treatment of acute renal allograft rejection with OKT3 monoclonal antibody
19. A randomized clinical trial of OKT3 monoclonal antibody for acute rejection of cadaveric renal transplants
20. Cytokine-related syndrome following injection of anti-CD3 monoclonal antibody: further evidence for transient in vivo T cell activation
21. Systemic reaction to the anti-T-cell monoclonal antibody OKT3 in relation to serum levels of tumor necrosis factor and interferon-α
22. Release of tumor necrosis factor, interleukin-2, and gamma-interferon in serum after injection of OKT3 monoclonal antibody in kidney transplant recipients
23. Evidence that antihuman tumor necrosis factor monoclonal antibody prevents OKT3-induced acute syndrome
24. The anti-CD3-induced syndrome: a consequence of massive in vivo cell activation
25. Murine hepatocyte apoptosis induced in vitro and in vivo by TNF-α requires transcriptional arrest
26. Galactosamine-induced sensitized to the lethal effects of endotoxin
27. Galactosamine hepatitis: key role of the nucleotide deficiency period in the pathogenesis of cell injury and cell death
28. Tumor necrosis factor mediates endotoxin shock: the protective effects of antibodies and cortisone
29. Leukocyte alterations do not account for hepatitis induced by endotoxin or TNF-α in galactosamine-sensitized mice
30. Multiple organ failure
31. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor tumor necrosis factor from human monocytes
32. An improved assay for the measurement of IL-2
33. Enzymatic method for quantitative determination of nanogram amounts of total and oxidised glutathione: application to mammalian blood and other tissues
34. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
35. Genetic basis for unresponsiveness to LPS in C57BL/10Cr mice
36. TNF-α mediates lethal activity of killed gram-negative and gram-positive bacteria in d-galactosamine-treated mice
37. Hepatic injury and lethal shock in galactosamine-sensitized mice induced by the superantigen staphylococcal enterotoxin B
38. Binding of radioactively labelled concanavalin A and wheat germ agglutinin to normal and virus-transformed cells
39. 3H-concanavalin A by normal and transformed cells
40. Lectin binding to adult rat liver in situ, isolated hepatocytes and hepatocyte cultures
41. Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen
42. Leukocytosis and resitance to septic shock in intracellular adhesion molecule 1-deficient mice
43. Inhibition of cytokine production by cyclosporin A and transforming growth factor β
44. Cyclosporin A inhibits tumor necrosis factor production without decreasing mRNA levels
45. Anti-Tumor necrosis factor modulates anti-CD3-triggered T cell cytokine gene expression in vivo
46. Purification of cachectin, a lipoprotein lipase-suppressing hormone secreted by endotoxin-induced RAW 264.7 cells
47. Cytotoxic mechanisms of tumor necrosis factor-α
48. Purification and characterization of the Fas ligand that induces apoptosis
49. Lethal effect of the anti-Fas antibody in mice
50. Recombinant tumor necrosis factor causes activation of human granulocytes
51. Tumor necrosis factor (TNF) mediates lipopolysaccharide (LPS)-elicited neutrophil sticking to sinusoidal endothelial cells in vivo
52. Modulation of endothelial cell hemostatic properties by TNF: insights into the role of endothelium in host response to inflammatory stimuli